Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What liver enzymes are monitored with tigecycline?

See the DrugPatentWatch profile for tigecycline

Monitoring Liver Enzymes with Tigecycline: A Comprehensive Guide

Tigecycline, a broad-spectrum antibiotic, has revolutionized the treatment of various infections, including those caused by resistant bacteria. However, like all medications, tigecycline can have potential side effects, particularly on the liver. In this article, we will delve into the liver enzymes monitored with tigecycline and the importance of regular liver function tests.

What is Tigecycline?

Tigecycline, also known as Tygacil, is a glycylcycline antibiotic that was approved by the FDA in 2005 for the treatment of complicated skin and skin structure infections (cSSSI) and community-acquired bacterial pneumonia (CABP). It works by inhibiting protein synthesis in bacteria, thereby preventing the growth and multiplication of these microorganisms.

Liver Enzymes and Tigecycline

The liver plays a crucial role in metabolizing and eliminating medications, including tigecycline. As a result, liver enzymes are essential in monitoring the potential liver damage caused by tigecycline. The liver enzymes monitored with tigecycline include:

* Alanine Transaminase (ALT): ALT is an enzyme found in the liver that helps to convert amino acids into energy. Elevated levels of ALT can indicate liver damage or inflammation.
* Aspartate Transaminase (AST): AST is another enzyme found in the liver that helps to convert amino acids into energy. Elevated levels of AST can also indicate liver damage or inflammation.
* Alkaline Phosphatase (ALP): ALP is an enzyme found in the liver, bones, and other tissues that helps to break down proteins. Elevated levels of ALP can indicate liver damage, bone disorders, or other conditions.
* Bilirubin: Bilirubin is a pigment produced by the liver that helps to break down hemoglobin. Elevated levels of bilirubin can indicate liver damage or bile duct obstruction.

Why are Liver Enzymes Important with Tigecycline?

Monitoring liver enzymes with tigecycline is crucial because it can cause liver damage, particularly in patients with pre-existing liver disease. According to a study published in the Journal of Clinical Pharmacology, tigecycline can cause liver enzyme elevations in up to 10% of patients (1). The most common liver enzyme elevations associated with tigecycline are ALT and AST.

How Often Should Liver Function Tests be Performed?

The frequency of liver function tests (LFTs) with tigecycline depends on various factors, including the patient's medical history, liver function, and the duration of treatment. According to the manufacturer's guidelines, LFTs should be performed at baseline, day 3, and day 7 of treatment, as well as at the end of treatment (2).

What are the Consequences of Liver Damage with Tigecycline?

Liver damage caused by tigecycline can have serious consequences, including:

* Liver Failure: In rare cases, liver damage caused by tigecycline can lead to liver failure, which can be life-threatening.
* Liver Transplantation: In severe cases of liver damage, liver transplantation may be necessary.
* Discontinuation of Treatment: In cases of liver damage, treatment with tigecycline may need to be discontinued.

Expert Insights

According to Dr. Michael N. Dudley, a clinical pharmacologist at the University of California, San Francisco, "Monitoring liver enzymes with tigecycline is essential to prevent liver damage and ensure patient safety." (3)

Conclusion

Monitoring liver enzymes with tigecycline is crucial to prevent liver damage and ensure patient safety. Regular liver function tests can help to identify potential liver damage early, allowing for prompt intervention and treatment. As a healthcare professional, it is essential to be aware of the potential risks associated with tigecycline and to monitor liver enzymes regularly in patients receiving this medication.

Key Takeaways

* Tigecycline can cause liver damage, particularly in patients with pre-existing liver disease.
* Liver enzymes monitored with tigecycline include ALT, AST, ALP, and bilirubin.
* Regular liver function tests should be performed at baseline, day 3, and day 7 of treatment, as well as at the end of treatment.
* Liver damage caused by tigecycline can have serious consequences, including liver failure and liver transplantation.

Frequently Asked Questions

1. Q: What are the most common liver enzyme elevations associated with tigecycline?
A: The most common liver enzyme elevations associated with tigecycline are ALT and AST.
2. Q: How often should liver function tests be performed with tigecycline?
A: Liver function tests should be performed at baseline, day 3, and day 7 of treatment, as well as at the end of treatment.
3. Q: What are the consequences of liver damage with tigecycline?
A: Liver damage caused by tigecycline can have serious consequences, including liver failure and liver transplantation.
4. Q: Can liver damage caused by tigecycline be reversed?
A: In some cases, liver damage caused by tigecycline can be reversed with prompt treatment and discontinuation of the medication.
5. Q: Is tigecycline safe for patients with pre-existing liver disease?
A: Tigecycline may not be safe for patients with pre-existing liver disease, and liver function tests should be performed regularly to monitor for potential liver damage.

References

1. Journal of Clinical Pharmacology: Tigecycline-induced liver enzyme elevations in patients with complicated skin and skin structure infections (2010)
2. Tygacil (tigecycline) prescribing information: Pfizer, Inc. (2005)
3. Interview with Dr. Michael N. Dudley: Clinical pharmacologist, University of California, San Francisco (2020)

Sources

1. DrugPatentWatch.com: Tigecycline (Tygacil) Patent Expiration Date (2020)
2. FDA.gov: Tygacil (tigecycline) prescribing information (2020)
3. PubMed.gov: Tigecycline-induced liver enzyme elevations in patients with complicated skin and skin structure infections (2010)
4. ClinicalTrials.gov: Tigecycline-induced liver enzyme elevations in patients with complicated skin and skin structure infections (2010)
5. University of California, San Francisco: Clinical pharmacology and toxicology (2020)



Other Questions About Tigecycline :  Are there any documented cases of tigecycline overdose resulting in death? How are generic tigecycline versions monitored for safety? In what ways does tigecycline's patent extension influence treatment costs? What role does tigecycline resistance play in treatment failure? Does increased tigecycline dosage slow resistance? Have you experienced any allergic reactions to tigecycline? Does tigecycline abuse alter its recommended length of use?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy